Monoethanolamine

Monoethanolamine

SCHEMBL428820

CCCCCCCCCCCCCOS(=O)(=O)O.NCCO.NCCO

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MPL

The experimentally established mechanism targets of Monoethanolamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 11/20 0.55
CA2 P00918 11/20 0.55
CA9 Q16790 9/20 0.55
CA12 O43570 3/20 0.55
CA7 P43166 3/20 0.55
CA14 Q9ULX7 3/20 0.55
CA3 P07451 2/20 0.55
CA4 P22748 2/20 0.55
CA6 P23280 2/20 0.55
CA5A P35218 2/20 0.55
CA5B Q9Y2D0 2/20 0.55
RECQL P46063 2/20 0.48
GLA P06280 1/20 0.48
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
EPHX2 P34913 1/20 0.48
BLM P54132 1/20 0.48
MEN1 O00255 1/20 0.42
THRB P10828 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Monoethanolamine SCHEMBL11414843 1.00 CA1 (0.55) CA1CA2CA9CA12CA7
Octadecyl Sulfate SCHEMBL8343031 1.00 CA1 (0.55) CA1CA2CA9CA12CA7
Monoethanolamine SCHEMBL11028488 1.00 CA1 (0.55) CA1CA2CA9CA12CA7
Monoethanolamine SCHEMBL378930 1.00 CA1 (0.55) CA1CA2CA9CA12CA7
Monoethanolamine SCHEMBL11580345 1.00 CA1 (0.55) CA1CA2CA9CA12CA7
Monoethanolamine SCHEMBL11580773 1.00 CA1 (0.55) CA1CA2CA9CA12CA7
Monoethanolamine SCHEMBL28720260 1.00 CA1 (0.55) CA1CA2CA9CA12CA7
Monoethanolamine SCHEMBL430867 1.00 CA1 (0.55) CA1CA2CA9CA12CA7
Monoethanolamine SCHEMBL7588149 1.00 CA1 (0.55) CA1CA2CA9CA12CA7
Octadecyl Sulfate SCHEMBL3963770 1.00 CA1 (0.55) CA1CA2CA9CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019109243-A1 Cosmetic composition for permanently changing the shape of keratinous fibers HENKEL AG & CO.KGAA (DE) 2019-06-13 WO disclosed
EP-2136768-B1 STRUCTURED SURFACTANT COMPOSITIONS SOLVAY USA INC (US) 2018-10-17 EP disclosed
EP-2419077-B1 PROCESS OF TREATING DAMAGED HAIR RHODIA OPERATIONS (FR) 2016-10-12 EP disclosed
EP-2393469-B1 Process of treating hair RHODIA OPERATIONS (FR) 2016-10-12 EP disclosed
US-20140308227-A1 PROCESS OF TREATING DAMAGED HAIR RHODIA OPERATIONS (FR) 2014-10-16 US disclosed
US-8828364-B2 Structured surfactant compositions RHODIA OPERATIONS (FR) 2014-09-09 US disclosed
EP-2419077-A2 PROCESS OF TREATING DAMAGED HAIR Rhodia Opérations (FR) 2012-02-22 EP disclosed
US-20120021025-A1 AQUEOUS COMPOSITION SUITABLE AS SHAMPOO RHODIA OPERATIONS (FR) 2012-01-26 US disclosed
WO-2010089228-A9 AQUEOUS COMPOSITION SUITABLE AS SHAMPOO RHODIA OPERATIONS (FR) 2011-04-21 WO disclosed
WO-2010118925-A2 PROCESS OF TREATING DAMAGED HAIR RHODIA OPERATIONS (FR) 2010-10-21 WO disclosed
WO-2010089228-A1 AQUEOUS COMPOSITION SUITABLE AS SHAMPOO RHODIA OPERATIONS (FR) 2010-08-12 WO disclosed
EP-2216010-A1 Aqueous composition suitable as shampoo Rhodia Opérations (FR) 2010-08-11 EP disclosed
EP-2136768-A1 STRUCTURED SURFACTANT COMPOSITIONS Rhodia, Inc. (US) 2009-12-30 EP disclosed
WO-2008118381-A1 STRUCTURED SURFACTANT COMPOSITIONS RHODIA INC. (US) 2008-10-02 WO disclosed
US-20080233061-A1 Alkyl ether sulfate surfactant, alkyl sulfate surfactant, alkanolamide surfactant,amphoteric surfactant, and electrolyte; opacity, yield strength; sodium trideceth sulfate, sodium lauryl sulfate, ammonium lauryl sulfate, sodium lauroamphoacetate, coco monoethanolamide, ammonium chloride, citric acid SPECIALTY OPERATIONS FRANCE (FR) 2008-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080233061-A1 Alkyl ether sulfate surfactant, alkyl sulfate surfactant, alkanolamide surfactant,amphoteric surfactant, and electrolyte; opacity, yield strength; sodium trideceth sulfate, sodium lauryl sulfate, ammonium lauryl sulfate, sodium lauroamphoacetate, coco monoethanolamide, ammonium chloride, citric acid SGMS2, SGMS1, ACMSD CA1 100/4885CA2 13/4885CA9 171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.